BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22953786)

  • 1. Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure.
    Wen Y; Chen B; Wang C; Ma X; Gao Q
    Expert Opin Biol Ther; 2012 Dec; 12(12):1563-73. PubMed ID: 22953786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.
    Wen Y; Meng L; Ding Y; Ouyang J
    Int J Clin Pract; 2011 Aug; 65(8):858-65. PubMed ID: 21762310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of autologous bone marrow-derived cells transfer for patients with chronic ischemic heart disease: a meta-analysis].
    Zhang CY; Sun AJ; Ge JB; Zhang SN; Wang KQ; Zou YZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):656-61. PubMed ID: 21055294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up].
    Gao LR; Wang ZG; Tian HT; Zhu ZM; Fei YX; Xu HT; Chen Y; Zhu JR; He S; Zhang NK; Ding QA; Yang Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):685-9. PubMed ID: 17553306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis.
    Xu R; Ding S; Zhao Y; Pu J; He B
    Can J Cardiol; 2014 Nov; 30(11):1370-7. PubMed ID: 24726092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived mononuclear cell therapy for nonischaemic dilated cardiomyopathy-A meta-analysis.
    Wen Y; Ding J; Zhang B; Gao Q
    Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy.
    Kandala J; Upadhyay GA; Pokushalov E; Wu S; Drachman DE; Singh JP
    Am J Cardiol; 2013 Jul; 112(2):217-25. PubMed ID: 23623290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis.
    Ye Z; Zhang BL; Zhao XX; Qin YW; Wu H; Cao J; Zhang JL; Hu JQ; Zheng X; Xu RL
    Heart Lung Circ; 2012 Nov; 21(11):725-33. PubMed ID: 22898593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramyocardial Autologous Bone Marrow-derived Stem Cells Injection for Ischemic Heart Disease Ineligible for Revascularization: A Systematic Review and Meta-analysis.
    Zhu K; Li J; Wang Y; Luo J; Zhang W; Guo C; Lai H; Wang C
    Arch Med Res; 2015 May; 46(4):286-95. PubMed ID: 26070842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
    Tian T; Chen B; Xiao Y; Yang K; Zhou X
    Atherosclerosis; 2014 Apr; 233(2):485-492. PubMed ID: 24530783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis.
    Wen Y; Meng L; Xie J; Ouyang J
    Expert Opin Biol Ther; 2011 May; 11(5):559-67. PubMed ID: 21388335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stem cell transplantation on patients with ischemic heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Xu F; Ma J; Shi J; Chen S; Liu Z; Liu J
    Stem Cell Res Ther; 2019 Apr; 10(1):125. PubMed ID: 30999928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of medical therapy on left ventricular ejection fraction in patients with systolic heart failure and narrow QRS duration with and without ischemic heart disease and left ventricular mechanical dyssynchrony.
    Nair CK; Shen X; Aronow WS; Li H; Holmberg MJ; Korlakunta H; Hee T; Maciejewski S; Esterbrooks DJ
    Am J Ther; 2010; 17(1):e1-7. PubMed ID: 19262361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.
    Afzal MR; Samanta A; Shah ZI; Jeevanantham V; Abdel-Latif A; Zuba-Surma EK; Dawn B
    Circ Res; 2015 Aug; 117(6):558-75. PubMed ID: 26160853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.
    Brunskill SJ; Hyde CJ; Doree CJ; Watt SM; Martin-Rendon E
    Eur J Heart Fail; 2009 Sep; 11(9):887-96. PubMed ID: 19654139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
    Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
    Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.
    Zimmet H; Porapakkham P; Porapakkham P; Sata Y; Haas SJ; Itescu S; Forbes A; Krum H
    Eur J Heart Fail; 2012 Jan; 14(1):91-105. PubMed ID: 22065869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.